SVP Research @ Five Prime Therapeutics, Inc. (September 2016 - August 2017)
VP Immuno-Oncology Research @ Five Prime Therapeutics, Inc. (July 2015 - September 2016)
Executive Director @ Five Prime Therapeutics, Inc. (February 2015 - June 2015)
Senior Director @ Five Prime Therapeutics, Inc. (May 2014 - January 2015)
Scientific Director @ (November 2011 - May 2014)
Scientific Director @ (January 2006 - January 2011)
Scientific Director @ (January 2005 - January 2006)
Principal Scientist @ (January 2004 - January 2005)
Research Scientist @ (January 2003 - January 2004)
Scientist @ (January 1999 - January 2002)
Post-doctoral scientist @ (January 1996 - January 1999)
Post-doctoral scientist @ (January 1995 - January 1996)
Luis Borges Education
University of Washington - School of Medicine
Ph.D (Department of Pathology)
1990-1995
University of Lisbon
Marine Biology (Marine Biology)
1980-1985
Luis Borges Skills
Monoclonal Antibodies
Lifesciences
Antibodies
Drug Discovery
Biotechnology
Immunology
Cell Culture
In Vivo
Biomarkers
ELISA
Drug Development
Biopharmaceuticals
Assay Development
Oncology
Molecular Biology
In Vitro
Cell
Immunotherapy
Biologics
Hematology
Animal Models
Cancer Research
Cancer
Inflammation
Biomarker Discovery
Immunoassays
Toxicology
Life Sciences
Science
Customer Service
Pharmaceutical Industry
Project Management
Program Management
Leadership
Luis Borges Summary
Luis Borges, based in Houston, TX, US, is currently a Founder and CEO at Artemia Therapeutics. Luis Borges brings experience from previous roles at Artemia Therapeutics, Borges Biotech Advisors LLC, Shinobi Therapeutics and Self-employed. Luis Borges holds a 1990 - 1995 Ph.D in Department of Pathology @ University of Washington - School of Medicine. With a robust skill set that includes Monoclonal Antibodies, Lifesciences, Antibodies, Drug Discovery, Biotechnology and more. Luis Borges has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Luis Borges?
Find contact details for 700 million professionals.